Moaz O. Moursi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Moaz O. Moursi has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Alreem Al-Naimi
Department of Medical Education, Hamad Medical Corporation, Doha, Qatar
2 shared publicationsHaya Salem
College of Medicine, QU Health, Qatar University, Doha, Qatar
2 shared publicationsLolwa Alansari
Department of Obstetrics and Gynecology, Al-Wakra Hospital, Al-Wakrah,Qatar
2 shared publicationsMaha Al-Ajmi
College of Medicine, QU Health, Qatar University, Doha, Qatar
2 shared publicationsMuhammad Zahid
Department of Internal Medicine, Hamad General Hospital , Doha
2 shared publicationsSara Al-Meraghi
College of Medicine, QU Health, Qatar University, Doha, Qatar
2 shared publications
Latest Publications
- Open Access
- 28 May 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (5)
Hepatic vena cava syndrome: a case report and literature review
Background: Hepatic vena cava syndrome (HVCS) is an uncommon condition, with no prior reports from the Gulf area. In regions with limited resources, where this disease is found, there is a lack of data due to underdiagnosis. HVCS results from recurrent bacterial thrombophlebitis of the hepatic portion of the inferior vena cava (IVC), causing intimal thickening and obstruction, eventually leading to complications like liver cirrhosis and hepatocellular carcinoma. Case presentation: A 32-year-old Afghan refugee lady, presented with progressive abdominal distention. Initial investigations showed anemia, splenomegaly, and massive ascites. Further investigations revealed cirrhotic liver, varices, and a stenotic segment of the IVC. She was diagnosed with HVCS, underwent IVC stenting, and commenced on clopidogrel and dabigatran. Conclusion Often misdiagnosed, HVCS requires a high index of suspicion and should be considered in patients with liver cirrhosis with low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma. Key clinical message Often misdiagnosed, Hepatic Vena Cava Syndrome requires a high index of suspicion and should be considered in low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma.
- 28 May 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (5)
Open AccessHepatic vena cava syndrome: a case report and literature review
Background: Hepatic vena cava syndrome (HVCS) is an uncommon condition, with no prior reports from the Gulf area. In regions with limited resources, where this disease is found, there is a lack of data due to underdiagnosis. HVCS results from recurrent bacterial thrombophlebitis of the hepatic portion of the inferior vena cava (IVC), causing intimal thickening and obstruction, eventually leading to complications like liver cirrhosis and hepatocellular carcinoma. Case presentation: A 32-year-old Afghan refugee lady, presented with progressive abdominal distention. Initial investigations showed anemia, splenomegaly, and massive ascites. Further investigations revealed cirrhotic liver, varices, and a stenotic segment of the IVC. She was diagnosed with HVCS, underwent IVC stenting, and commenced on clopidogrel and dabigatran. Conclusion Often misdiagnosed, HVCS requires a high index of suspicion and should be considered in patients with liver cirrhosis with low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma. Key clinical message Often misdiagnosed, Hepatic Vena Cava Syndrome requires a high index of suspicion and should be considered in low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma.
- Open Access
- 26 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (3) , e70153
Sweet Syndrome With Painless Skin Lesions and Myopericarditis: A Case Report and Literature Review
Sweet syndrome is a rare inflammatory disease that typically presents with painful erythematous skin lesions and fever. Although the skin lesions are generally painful on clinical examination, in this case, they were noted to be painless without tenderness. Moreover, our case is unique in that this patient had myopericarditis, a rare extracutaneous manifestation of sweet syndrome.
- 26 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (3) , e70153
Open AccessSweet Syndrome With Painless Skin Lesions and Myopericarditis: A Case Report and Literature Review
Sweet syndrome is a rare inflammatory disease that typically presents with painful erythematous skin lesions and fever. Although the skin lesions are generally painful on clinical examination, in this case, they were noted to be painless without tenderness. Moreover, our case is unique in that this patient had myopericarditis, a rare extracutaneous manifestation of sweet syndrome.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Immunology
- Vol. 2025 (1) , 5533371
Diagnostic Dilemma: Adult Onset Still’s Disease Mimicking Lymphoma—A Case Report and Literature Review
Introduction: Adult‐onset Still’s disease (AOSD) is a rare systemic inflammatory condition with hallmark features of spiking fevers, arthritis, and a salmon‐colored maculopapular rash. It typically affects young adults, with a bimodal age distribution of 15–25 and 36–46 years. The prevalence of AOSD ranges from 1 to 34 cases per million people, with an incidence rate of 0.16–0.4 per 100,000 individuals. AOSD’s etiology remains unclear but is thought to involve genetic and environmental factors. Diagnosis relies on clinical criteria, such as the Yamaguchi criteria, and exclusion of other conditions. Misdiagnosis is common, particularly in regions where infections and malignancies with overlapping features are prevalent. This case report highlights a diagnostically challenging case of AOSD in a young woman, emphasizing the importance of thorough evaluation and accurate diagnosis. Case Presentation: A 21‐year‐old female with no prior comorbidities presented with persistent fever, a transient salmon‐colored rash, and polyarthritis involving the wrists, shoulders, ankles, and small joints. Three months prior, she had been treated for left submandibular sialadenitis attributed to mumps. Laboratory work revealed elevated C‐reactive protein (CRP), ferritin, and LDH levels with a normal erythrocyte sedimentation rate (ESR) and autoimmune profile. Imaging studies, including PET‐CT, suggested malignancy, raising suspicion of lymphoma. However, lymph node biopsy showed reactive hyperplasia without evidence of malignancy. Ultimately, a diagnosis of AOSD was established based on clinical and laboratory findings. The patient was initiated on anakinra and prednisolone, leading to significant improvement. At a 2‐month follow‐up, she had complete resolution of symptoms. Conclusion: AOSD presents a significant diagnostic challenge due to its rarity and symptom overlap with infections, malignancies, and autoimmune diseases. This case highlights the importance of a thorough clinical evaluation and the application of established diagnostic criteria to facilitate early diagnosis and timely management.
- 1 January 2025
- Published by Wiley in Case Reports in Immunology
- Vol. 2025 (1) , 5533371
Open AccessDiagnostic Dilemma: Adult Onset Still’s Disease Mimicking Lymphoma—A Case Report and Literature Review
Introduction: Adult‐onset Still’s disease (AOSD) is a rare systemic inflammatory condition with hallmark features of spiking fevers, arthritis, and a salmon‐colored maculopapular rash. It typically affects young adults, with a bimodal age distribution of 15–25 and 36–46 years. The prevalence of AOSD ranges from 1 to 34 cases per million people, with an incidence rate of 0.16–0.4 per 100,000 individuals. AOSD’s etiology remains unclear but is thought to involve genetic and environmental factors. Diagnosis relies on clinical criteria, such as the Yamaguchi criteria, and exclusion of other conditions. Misdiagnosis is common, particularly in regions where infections and malignancies with overlapping features are prevalent. This case report highlights a diagnostically challenging case of AOSD in a young woman, emphasizing the importance of thorough evaluation and accurate diagnosis. Case Presentation: A 21‐year‐old female with no prior comorbidities presented with persistent fever, a transient salmon‐colored rash, and polyarthritis involving the wrists, shoulders, ankles, and small joints. Three months prior, she had been treated for left submandibular sialadenitis attributed to mumps. Laboratory work revealed elevated C‐reactive protein (CRP), ferritin, and LDH levels with a normal erythrocyte sedimentation rate (ESR) and autoimmune profile. Imaging studies, including PET‐CT, suggested malignancy, raising suspicion of lymphoma. However, lymph node biopsy showed reactive hyperplasia without evidence of malignancy. Ultimately, a diagnosis of AOSD was established based on clinical and laboratory findings. The patient was initiated on anakinra and prednisolone, leading to significant improvement. At a 2‐month follow‐up, she had complete resolution of symptoms. Conclusion: AOSD presents a significant diagnostic challenge due to its rarity and symptom overlap with infections, malignancies, and autoimmune diseases. This case highlights the importance of a thorough clinical evaluation and the application of established diagnostic criteria to facilitate early diagnosis and timely management.
- Open Access
- 31 December 2024
- Published by Wiley in Clinical Case Reports
- Vol. 13 (1) , e9574
Cerebral Venous Sinus Thrombosis Linked to Dietary Supplement Use in a Bodybuilder: A Case Report
Many dietary supplements commonly used by bodybuilders and athletes carry thrombogenic risks, potentially leading to life‐threatening conditions like arterial and venous thrombosis by either elevating testosterone levels or directly interfering with homeostasis. Increased awareness and further research are crucial for consumer safety and supplement regulation.
- 31 December 2024
- Published by Wiley in Clinical Case Reports
- Vol. 13 (1) , e9574
Open AccessCerebral Venous Sinus Thrombosis Linked to Dietary Supplement Use in a Bodybuilder: A Case Report
Many dietary supplements commonly used by bodybuilders and athletes carry thrombogenic risks, potentially leading to life‐threatening conditions like arterial and venous thrombosis by either elevating testosterone levels or directly interfering with homeostasis. Increased awareness and further research are crucial for consumer safety and supplement regulation.
- Open Access
- 10 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8794
Ischemic stroke as an initial presentation of neurosyphilis in a newly diagnosed HIV patient: A case report and literature review
Key Clinical Message: With syphilis resurgence, physicians should be more vigilant to infection‐induced cerebral vasculitis in high‐risk patients presenting with neurological symptoms. In this case, neurosyphilis should not be missed. Thorough serologic screening and lumbar puncture are crucial for diagnosis, and further research is needed for safe and effective treatments in these populations.
- 10 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8794
Open AccessIschemic stroke as an initial presentation of neurosyphilis in a newly diagnosed HIV patient: A case report and literature review
Key Clinical Message: With syphilis resurgence, physicians should be more vigilant to infection‐induced cerebral vasculitis in high‐risk patients presenting with neurological symptoms. In this case, neurosyphilis should not be missed. Thorough serologic screening and lumbar puncture are crucial for diagnosis, and further research is needed for safe and effective treatments in these populations.
- Open Access
- 10 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8819
Coexistence of brain capillary telangiectasia and venous angioma: A case report and literature review
Key Clinical Message: While Cerebral vascular malformations exhibit distinct clinical and radiographical features, rare instances of coexisting lesions occur. This case report sheds light on the rare coexistence of brain capillary telangiectasia and venous angioma in a patient presenting with a seizure attributed to frontal lobe bleeding. Though often silent, brain capillary telangiectasia can manifest with serious life‐threatening intracranial bleeding. Therefore, in cases of spontaneous intracranial bleeding, an MRI of the head is crucial to rule out such cerebral vascular malformations.
- 10 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8819
Open AccessCoexistence of brain capillary telangiectasia and venous angioma: A case report and literature review
Key Clinical Message: While Cerebral vascular malformations exhibit distinct clinical and radiographical features, rare instances of coexisting lesions occur. This case report sheds light on the rare coexistence of brain capillary telangiectasia and venous angioma in a patient presenting with a seizure attributed to frontal lobe bleeding. Though often silent, brain capillary telangiectasia can manifest with serious life‐threatening intracranial bleeding. Therefore, in cases of spontaneous intracranial bleeding, an MRI of the head is crucial to rule out such cerebral vascular malformations.
- Open Access
- 13 August 2023
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 39 (1) , 2247098
The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
Anti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of polycystic ovarian morphology. In polycystic ovary syndrome (PCOS), an elevated level of AMH has been suggested to add value to the Rotterdam criteria in cases of diagnostic uncertainty. In this study, we evaluated the correlation between AMH and PCOS, and the potential role of AMH in PCOS diagnosis. A case-control study was performed on a total of 200 females, 100 of which were diagnosed with PCOS as per Rotterdam revised criteria (2003) and 100 as the control (non-PCOS group). Patient medical records were therefore retrieved for clinical, biochemical and ultrasound markers for PCOS diagnosis. Sensitivity, specificity, area under receiver operating characteristic (AUROC) curve, and multivariate linear regression models were applied to analyze our data. Mean serum levels of LH and AMH, and LH/FSH ratio were significantly different between compared groups. In the PCOS group, the mean serum AMH level was 6.78 ng/mL and LH/FSH ratio was 1.53 while those of controls were 2.73 ng/mL and 0.53, respectively (p < .001). The most suitable compromise between 81% specificity and 79% sensitivity was obtained with a cutoff value of 3.75 ng/mL (26.78 pmol/L) serum AMH concentration for PCOS prediction, with an AUROC curve of 0.9691. Serum AMH cutoff level of 3.75 ng/mL was identified as a convenient gauge for the prediction of PCOS and an adjuvant to the Rotterdam criteria.
- 13 August 2023
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 39 (1) , 2247098
Open AccessThe role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
Anti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of polycystic ovarian morphology. In polycystic ovary syndrome (PCOS), an elevated level of AMH has been suggested to add value to the Rotterdam criteria in cases of diagnostic uncertainty. In this study, we evaluated the correlation between AMH and PCOS, and the potential role of AMH in PCOS diagnosis. A case-control study was performed on a total of 200 females, 100 of which were diagnosed with PCOS as per Rotterdam revised criteria (2003) and 100 as the control (non-PCOS group). Patient medical records were therefore retrieved for clinical, biochemical and ultrasound markers for PCOS diagnosis. Sensitivity, specificity, area under receiver operating characteristic (AUROC) curve, and multivariate linear regression models were applied to analyze our data. Mean serum levels of LH and AMH, and LH/FSH ratio were significantly different between compared groups. In the PCOS group, the mean serum AMH level was 6.78 ng/mL and LH/FSH ratio was 1.53 while those of controls were 2.73 ng/mL and 0.53, respectively (p < .001). The most suitable compromise between 81% specificity and 79% sensitivity was obtained with a cutoff value of 3.75 ng/mL (26.78 pmol/L) serum AMH concentration for PCOS prediction, with an AUROC curve of 0.9691. Serum AMH cutoff level of 3.75 ng/mL was identified as a convenient gauge for the prediction of PCOS and an adjuvant to the Rotterdam criteria.
- 25 November 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (12) , S54-S55
Abstract #1316108: The Role of Anti-Mullerian Hormone and Other Correlates in Polycystic Ovary Syndrome Patients
- 25 November 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (12) , S54-S55
Abstract #1316108: The Role of Anti-Mullerian Hormone and Other Correlates in Polycystic Ovary Syndrome Patients
- Open Access
- 25 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (19) , 12114
The Association between Early Opioids Prescribing and the Length of Disability in Acute Lower Back Pain: A Systematic Review and Narrative Synthesis
Background: There is conflicting evidence with respect to whether early opioid prescribing (EOP) within the first two weeks of acute Low Back Pain (LBP) onset is associated with the length of disability (LOD). The aim of this systematic review was to examine the relationship between EOP and LOD in individuals with acute LBP. Methods: A systematic search of Medline, EMBASE, and CINAHL was conducted. The Newcastle–Ottawa scale was used to assess the methodological quality of included studies. A narrative synthesis of findings was used owing to between-study heterogeneity. Results: Six cohort studies using workers’ compensation administrative data on 178,130 adults with LBP were included. Most studies were of good methodological quality. One study reported that LBP cases with EOP had higher LOD by 4 days than cases without EOP. Two studies reported that each 100 mg morphine equivalent amount (MEA) was associated with an increase in mean LOD by 0.4 day (95% confidence interval (CI): 0.3, 0.5) and 0.4 day (95% CI: 0.3, 0.4). One study showed that LBP cases with EOP had a higher hazard of continuation of time loss benefits by 1.94 (95% CI 1.86, 2.02). One study reported a dose–response relationship between MEA of EOP and LOD ranging between 5.2 days (95% CI 14.6, 25.0) for 1–140 mg MEA and 69.1 (95% CI 49.3, 89.0) for 450+ mg MEA. One study reported that LBP cases with EOP had a higher mean LOD by 3.8 days, but there was no statistically significant relationship between EOP and LOD (Hazard ratio 1.02; 95% CI 0.91, 1.13). Conclusions: The use of early opioid in the management of acute uncomplicated LBP is associated with prolonged disability duration. Further research on factors influencing inadequate adherence to evidence-based guidelines and optimal strategies to modify such factors may improve disability outcomes among patients presenting with acute LBP.
- 25 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (19) , 12114
Open AccessThe Association between Early Opioids Prescribing and the Length of Disability in Acute Lower Back Pain: A Systematic Review and Narrative Synthesis
Background: There is conflicting evidence with respect to whether early opioid prescribing (EOP) within the first two weeks of acute Low Back Pain (LBP) onset is associated with the length of disability (LOD). The aim of this systematic review was to examine the relationship between EOP and LOD in individuals with acute LBP. Methods: A systematic search of Medline, EMBASE, and CINAHL was conducted. The Newcastle–Ottawa scale was used to assess the methodological quality of included studies. A narrative synthesis of findings was used owing to between-study heterogeneity. Results: Six cohort studies using workers’ compensation administrative data on 178,130 adults with LBP were included. Most studies were of good methodological quality. One study reported that LBP cases with EOP had higher LOD by 4 days than cases without EOP. Two studies reported that each 100 mg morphine equivalent amount (MEA) was associated with an increase in mean LOD by 0.4 day (95% confidence interval (CI): 0.3, 0.5) and 0.4 day (95% CI: 0.3, 0.4). One study showed that LBP cases with EOP had a higher hazard of continuation of time loss benefits by 1.94 (95% CI 1.86, 2.02). One study reported a dose–response relationship between MEA of EOP and LOD ranging between 5.2 days (95% CI 14.6, 25.0) for 1–140 mg MEA and 69.1 (95% CI 49.3, 89.0) for 450+ mg MEA. One study reported that LBP cases with EOP had a higher mean LOD by 3.8 days, but there was no statistically significant relationship between EOP and LOD (Hazard ratio 1.02; 95% CI 0.91, 1.13). Conclusions: The use of early opioid in the management of acute uncomplicated LBP is associated with prolonged disability duration. Further research on factors influencing inadequate adherence to evidence-based guidelines and optimal strategies to modify such factors may improve disability outcomes among patients presenting with acute LBP.